Prestigious Award Recognizes Pioneering Body's Defenses Research

The Nobel Prize in Physiology or Medicine was awarded for transformative discoveries that clarify how the immune system attacks harmful infections while sparing the body's own cells.

A trio of esteemed scientists—Japan's Shimon Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—received this accolade.

Their work identified unique "security guards" within the defense system that remove malfunctioning defense cells capable of harming the body.

The findings are now enabling innovative treatments for immune disorders and cancer.

The laureates will divide a monetary award valued at 11m SEK.

Decisive Discoveries

"Their research has been essential for understanding how the body's defenses functions and the reason we don't all develop serious self-attack conditions," commented the head of the award panel.

The trio's studies address a core mystery: How does the immune system protect us from countless invaders while leaving our healthy cells unharmed?

The body's protection system uses immune cells that scan for signs of infection, including pathogens and germs it has not met before.

These cells utilize sensors—called recognition units—that are produced randomly in countless combinations.

This gives the defense network the ability to fight a broad range of threats, but the unpredictability of the mechanism unavoidably produces immune cells that can attack the body.

Protectors of the Immune System

Researchers previously understood that a portion of these problematic defense cells were destroyed in the immune organ—where white blood cells mature.

The latest Nobel Prize honors the discovery of T-reg cells—known as the body's "peacekeepers"—which patrol the body to neutralize any immune cells that assault the healthy cells.

We know that this process malfunctions in self-attack conditions such as type-1 diabetes, MS, and rheumatoid arthritis.

The prize committee stated, "These discoveries have laid the foundation for a novel area of investigation and accelerated the creation of new therapies, for example for cancer and immune disorders."

Regarding malignancies, T-regs block the body from attacking the tumor, so research are focused on lowering their numbers.

For autoimmune diseases, trials are testing increasing T-reg cells so the organism is not being harmed. A similar method could also be effective in reducing the risks of transplanted organ failure.

Pioneering Studies

Prof Shimon Sakaguchi, of a Japanese institution, conducted tests on rodents that had their immune gland extracted, leading to autoimmune disease.

He demonstrated that injecting immune cells from healthy mice could prevent the illness—suggesting there was a system for preventing defenders from harming the body.

Dr. Brunkow, from the a research center in Seattle, and Fred Ramsdell, currently at a biotech firm in a California city, were investigating an genetic immune disorder in mice and humans that led to the identification of a gene critical for the way T-regs operate.

"The pioneering work has revealed how the body's defenses is kept in check by regulatory T cells, preventing it from mistakenly targeting the healthy cells," said a leading biological science expert.

"The work is a remarkable illustration of how basic biological study can have broad implications for human health."